These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

822 related items for PubMed ID: 17645597

  • 1. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K, Yamakado K, Kinbara H, Nakatsuka A, Takeda K, Sugimura Y.
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [Abstract] [Full Text] [Related]

  • 2. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y, Kawanaka K, Ikeda O, Tamura Y, Yamashita Y.
    Acta Radiol; 2012 May 01; 53(4):410-4. PubMed ID: 22393159
    [Abstract] [Full Text] [Related]

  • 3. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience.
    Yamakado K, Nakatsuka A, Kobayashi S, Akeboshi M, Takaki H, Kariya Z, Kinbara H, Arima K, Yanagawa M, Hori Y, Kato H, Sugimura Y, Takeda K.
    Cardiovasc Intervent Radiol; 2006 May 01; 29(3):389-94. PubMed ID: 16502180
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA.
    Cancer; 2010 Jul 01; 116(13):3135-42. PubMed ID: 20564644
    [Abstract] [Full Text] [Related]

  • 6. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection.
    Rouvière O, Badet L, Murat FJ, Maréchal JM, Colombel M, Martin X, Lyonnet D, Gelet A.
    Cardiovasc Intervent Radiol; 2008 Jul 01; 31(3):595-603. PubMed ID: 18247086
    [Abstract] [Full Text] [Related]

  • 7. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy.
    Gebauer B, Werk M, Lopez-Hänninen E, Felix R, Althaus P.
    Cardiovasc Intervent Radiol; 2007 Jul 01; 30(4):644-9. PubMed ID: 17436034
    [Abstract] [Full Text] [Related]

  • 8. Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk.
    Ukimura O, Kawauchi A, Fujito A, Mizutani Y, Okihara K, Mikami K, Soh J, Nakamura T, Nakanishi H, Ushijima S, Miki T.
    Int J Urol; 2004 Dec 01; 11(12):1051-7. PubMed ID: 15663674
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Progression of renal tumors after laparoscopic radiofrequency ablation.
    Uribe PS, Costabile RA, Peterson AC.
    Urology; 2006 Nov 01; 68(5):968-71. PubMed ID: 17095053
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
    Xia JL, Ye SL, Zou JH, Ren ZG, Gan YH, Wang YH, Chen Y, Ge NL, Tang ZY, Yang BH.
    Ai Zheng; 2004 Sep 01; 23(9):977-80. PubMed ID: 15363186
    [Abstract] [Full Text] [Related]

  • 14. Radiofrequency ablation for renal tumors: our experience.
    Hiraoka K, Kawauchi A, Nakamura T, Soh J, Mikami K, Miki T.
    Int J Urol; 2009 Nov 01; 16(11):869-73. PubMed ID: 19735313
    [Abstract] [Full Text] [Related]

  • 15. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
    Liao GS, Yu CY, Shih ML, Chan DC, Liu YC, Yu JC, Chen TW, Hsieh CB.
    Eur J Surg Oncol; 2008 Jan 01; 34(1):61-6. PubMed ID: 17434711
    [Abstract] [Full Text] [Related]

  • 16. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.
    Clark TW, Malkowicz B, Stavropoulos SW, Sanchez R, Soulen MC, Itkin M, Patel A, Mondschein JI, Wein AJ.
    J Vasc Interv Radiol; 2006 Mar 01; 17(3):513-9. PubMed ID: 16567676
    [Abstract] [Full Text] [Related]

  • 17. Radiofrequency ablation of renal tumors in the solitary kidney.
    Krambeck AE, Farrell MA, Callstrom MR, Atwell TD, Charboneau JW, Chow GK, Dimarco DS, Patterson DE.
    Can J Urol; 2008 Aug 01; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
    [Abstract] [Full Text] [Related]

  • 18. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.
    Jpn J Clin Oncol; 2007 Sep 01; 37(9):658-72. PubMed ID: 17766723
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
    Elias D, Santoro R, Ouellet JF, Osmak L, de Baere T, Roche A.
    Hepatogastroenterology; 2004 Sep 01; 51(60):1788-91. PubMed ID: 15532827
    [Abstract] [Full Text] [Related]

  • 20. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
    Linden PA, Wee JO, Jaklitsch MT, Colson YL.
    Ann Thorac Surg; 2008 Feb 01; 85(2):420-3. PubMed ID: 18222236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.